Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7449464 Phthalazinone derivatives

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
June 24, 2004
Date of Patent
November 11, 2008
Patent Application Number
10876080
Patent Citations Received
‌
US Patent 11834458 Anti-cancer nuclear hormone receptor-targeting compounds
0
‌
US Patent 11975001 Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one
0
‌
US Patent 11952349 Anti-cancer nuclear hormone receptor-targeting compounds
0
‌
US Patent 12006314 Anti-cancer nuclear hormone receptor-targeting compounds
0
‌
US Patent 11788145 Epigeneiic silencing of NMT2
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7449464
Patent Primary Examiner
‌
James O. Wilson

Find more entities like US Patent 7449464 Phthalazinone derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.